Inventor · disambiguated record
Chang-Zheng Chen
Also filed as: CHEN CHANG · CHEN CHANG-ZHENG
12 granted patents·14 pending applications·30 citations·filing 2002–2024
87Inventor score
Files withACHELOIS BIOPHARMA INC10UNIV LELAND STANFORD JUNIOR5CHEN CHANG-ZHENG4INST BIOPHYSICS CAS3WHITEHEAD BIOMEDICAL INST2
Top patents by PatentIndex Score
26 records- 0184US9388466B2Precursor miRNA loop-modulated target regulationUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jul 12, 2016·7 cites·2 claims
- 0284US8106180B2Methods and products for expression of micro RNAsCHEN CHANG-ZHENG·Filed 2004·Granted Jan 31, 2012·10 cites·36 claims
- 0383US7803784B2Modulation of T cell signaling threshold and T cell sensitivity to antigensUNIV LELAND STANFORD JUNIOR·Filed 2007·Granted Sep 28, 2010·5 cites·18 claims
- 0479US8841437B2Precursor miRNA loop-modulated target regulationCHEN CHANG-ZHENG·Filed 2010·Granted Sep 23, 2014·5 cites·5 claims
- 0574US8247388B2Role of miRNA in T cell leukemiaCHEN CHANG-ZHENG·Filed 2009·Granted Aug 21, 2012·1 cites·7 claims
- 0669US11529385B2Lycium barbarum extracts, resulting compositions, methods of making and methods of using the sameINST BIOPHYSICS CAS·Filed 2021·Granted Dec 20, 2022·0 cites·17 claims
- 0769US8741860B2Modulation of T cell signaling threshold and T cell sensitivity to antigensLI QI-JING·Filed 2010·Granted Jun 3, 2014·2 cites·7 claims
- 0863US9364522B2Modulation of T cell signaling threshold and T cell sensitivity to antigensUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jun 14, 2016·0 cites·7 claims
- 0960US11453705B2Multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2021·Granted Sep 27, 2022·0 cites·16 claims
- 1060US8609832B2Methods and products for expression of micro RNAsCHEN CHANG-ZHENG·Filed 2011·Granted Dec 17, 2013·0 cites·11 claims
- 1160US2025073298A1Composition comprising homogeneous polysaccharide or derivative thereof and method of using the same to improve muscle satellite cellsINST BIOPHYSICS CAS·Filed 2024·Application pending·0 cites
- 1260US2025288662A1Multivalent display on enveloped particles with human oligomerization domainsACHELOIS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1358US2014187613A1METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 1458US2022332769A1Multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1557US9598695B2Modulation of T cell signaling threshold and T cell sensitivity to antigensUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Mar 21, 2017·0 cites·8 claims
- 1657US2024391979A1Hepatitis b virus antivirus (hbv-antivirus) compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1756US11135260B2Lycium barbarum extracts, resulting compositions, methods of making and methods of using the sameINST BIOPHYSICS CAS·Filed 2020·Granted Oct 5, 2021·0 cites·13 claims
- 1855US2025289867A1Multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1954US2024398902A1Multivalent interferon particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2050US2024360181A1Compositions and methods for multivalent surface display on enveloped particlesACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2149US2024254203A1Antibody-based antivirus compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2249US2021069245A1Mirna modulation of t cell signaling and uses thereofACHELOIS ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2347US2024252613A1Immune checkpoint multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2445US2002168660A1Stem cell self-renewal and lineage commitmentWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 2543US2009004668A1Pre-miRNA loop-modulated target regulationUNIV LELAND STANFORD JUNIOR·Filed 2008·Application pending·0 cites
- 2637US2022152098A1Methods of modulating cd160 function in the antigen-specific immune cell and uses thereofACHELOIS BIOPHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chang-Zheng Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →